MARGARET SELLERS: Open Payments
NPI 1871012526 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,509 in 108 payments from 19 companies in 2025. Trend: 2023 $2,132 · 2024 $2,245 · 2025 $2,509
Food & beverage: $2,409Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $464 |
| ABBVIE INC. | 17 | $331 |
| Janssen Biotech, Inc. | 10 | $279 |
| Radius Health, Inc. | 6 | $263 |
| GlaxoSmithKline, LLC. | 10 | $206 |
| UCB, Inc. | 9 | $175 |
| Janssen Pharmaceuticals, Inc | 1 | $153 |
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| Organon LLC | 5 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
Products named: TREMFYA, Tymlos, RINVOQ, BENLYSTA, Otezla, Bimzelx, SKYRIZI, SAPHNELO.
Industry payments across GA — which companies pay providers there.
